[Table/Fig-1]:
Parameter | Dobutamine | Levosimendan | Milrinone | p-value | |||
---|---|---|---|---|---|---|---|
n (%) or Mean (SD) |
95 % CI | n (%) or Mean (SD) |
95 % CI | n (%) or Mean (SD) |
95 % CI | ||
Male Female |
8 (40%) 12 (60%) |
- - |
12 (60%) 8 (40%) |
- - |
11(55%) 9 (45%) |
- - |
>0.99 |
ASA III IV |
3.15 (0.36) 17 (85%) 3 (15%) |
2.97 – 3.32 - - |
3.20 (0.41) 16 (80%) 4 (20%) |
3.00 – 3.39 - - |
3.15 (0.36) 17 (85%) 3 (15%) |
2.97 – 3.32 - - |
0.875 |
NYHA III IV |
3.1 (0.30) 18 (90%) 2 (10%) |
2.95 – 3.24 - - |
3.05 (0.39) 18 (90%) 2 (10%) |
2.86 – 3.23 - - |
3.1 (0.30) 18 (90%) 2 (10%) |
2.95 – 3.24 - - |
0.865 |
Age (years) Weight (Kg) Height (inch) BMI |
41.2 (11.7) 50.55 (8.74) 65.05 (3.63) 18.59 (2.55) |
35.68 – 46.71 46.45 – 54.64 63.34 – 66.75 17.39 – 19.78 |
37.05 (13.62) 53.75 (14.22) 63.15 (4.51) 20.65 (5.47) |
30.67 – 43.42 47.09 – 60.40 61.03 – 65.26 18.09 – 23.22 |
34.45 (14.5) 50.4 (14.77) 62 (3.50) 18.15 (2.65) |
27.65 – 41.24 43.48 – 57.31 60.35 – 63.34 16.90 – 19.39 |
0.579 0.645 0.107 0.093 |